
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Plasma circulating tumor DNA assessment reveals KMT2D as a potential poor prognostic factor in extranodal NK/T-cell lymphoma
Qiong Li, Wei Zhang, Jiali Li, et al.
Biomarker Research (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 32
Qiong Li, Wei Zhang, Jiali Li, et al.
Biomarker Research (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
Identifying KDM5B as the synthetic lethal target of KMT2D-mutated osteosarcoma
Liyu Yang, Jing Zhang, Yiting Jiang, et al.
Chemico-Biological Interactions (2025) Vol. 412, pp. 111451-111451
Closed Access
Liyu Yang, Jing Zhang, Yiting Jiang, et al.
Chemico-Biological Interactions (2025) Vol. 412, pp. 111451-111451
Closed Access
Circulating tumor DNA in lymphoma: technologies and applications
Lina Fu, Xue‐Rong Zhou, Xiaoyu Zhang, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Lina Fu, Xue‐Rong Zhou, Xiaoyu Zhang, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Liquid biopsy in T-cell lymphoma: biomarker detection techniques and clinical application
Zongyao Huang, Yao Fu, Yang Hong, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Zongyao Huang, Yao Fu, Yang Hong, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Applications of Circulating Tumor DNA in Myelodysplastic Syndromes and Acute Myeloid Leukemia: Promises and Challenges
Yuhang Xue, Xuejiao Xia, Xin Liu, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 2
Open Access | Times Cited: 3
Yuhang Xue, Xuejiao Xia, Xin Liu, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 2
Open Access | Times Cited: 3
Molecular Monitoring of Lymphomas
Joseph G. Schroers‐Martin, Stefan Alig, Andrea Garofalo, et al.
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 149-180
Open Access | Times Cited: 15
Joseph G. Schroers‐Martin, Stefan Alig, Andrea Garofalo, et al.
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 149-180
Open Access | Times Cited: 15
Tumor Immune Microenvironment in Lymphoma: Focus on Epigenetics
Daniel J. García-Domínguez, Lourdes Hontecillas‐Prieto, Natalia Palazón‐Carrión, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1469-1469
Open Access | Times Cited: 14
Daniel J. García-Domínguez, Lourdes Hontecillas‐Prieto, Natalia Palazón‐Carrión, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1469-1469
Open Access | Times Cited: 14
In-depth circulating tumor DNA sequencing for prognostication and monitoring in natural killer/T-cell lymphomas
Jin Ju Kim, Hyun‐Young Kim, Zisun Choi, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Jin Ju Kim, Hyun‐Young Kim, Zisun Choi, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Role of Circulating Tumor DNA in Hematological Malignancy
Miho Ogawa, Kazuaki Yokoyama, Seiya Imoto, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2078-2078
Open Access | Times Cited: 13
Miho Ogawa, Kazuaki Yokoyama, Seiya Imoto, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2078-2078
Open Access | Times Cited: 13
Mutation profiling, tumour burden assessment, outcome prediction and disease monitoring by circulating tumour DNA in peripheral T‐cell lymphoma
Chong Wei, Wei Wang, Yan Zhang, et al.
British Journal of Haematology (2023) Vol. 202, Iss. 1, pp. 86-95
Closed Access | Times Cited: 5
Chong Wei, Wei Wang, Yan Zhang, et al.
British Journal of Haematology (2023) Vol. 202, Iss. 1, pp. 86-95
Closed Access | Times Cited: 5
Diagnosis and monitoring of virus-associated cancer using cell-free DNA
Larissa LS Scholte, Jeffrey M. Bethony, Rena R. Xian
Current Opinion in Virology (2023) Vol. 60, pp. 101331-101331
Open Access | Times Cited: 5
Larissa LS Scholte, Jeffrey M. Bethony, Rena R. Xian
Current Opinion in Virology (2023) Vol. 60, pp. 101331-101331
Open Access | Times Cited: 5
Higher 13‐Gene‐Estimated TMB Detected from Plasma ctDNA is Associated with Worse Outcome for T‐Cell Lymphoma Patients
Cunte Chen, Ling Huang, Zheng Chen, et al.
Advanced Biology (2023) Vol. 7, Iss. 12
Closed Access | Times Cited: 5
Cunte Chen, Ling Huang, Zheng Chen, et al.
Advanced Biology (2023) Vol. 7, Iss. 12
Closed Access | Times Cited: 5
Clinical Application of Liquid Biopsy in Non-Hodgkin Lymphoma
Liwei Lv, Yuanbo Liu
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 12
Liwei Lv, Yuanbo Liu
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 12
Update on Molecular Diagnosis in Extranodal NK/T-Cell Lymphoma and Its Role in the Era of Personalized Medicine
Ka-Hei Sun, Yin-Ting Wong, Ka Man Cheung, et al.
Diagnostics (2022) Vol. 12, Iss. 2, pp. 409-409
Open Access | Times Cited: 8
Ka-Hei Sun, Yin-Ting Wong, Ka Man Cheung, et al.
Diagnostics (2022) Vol. 12, Iss. 2, pp. 409-409
Open Access | Times Cited: 8
Rational Targets of Therapy in Extranodal NK/T-Cell Lymphoma
Ajay Major, Pierluigi Porcu, Bradley M. Haverkos
Cancers (2023) Vol. 15, Iss. 5, pp. 1366-1366
Open Access | Times Cited: 4
Ajay Major, Pierluigi Porcu, Bradley M. Haverkos
Cancers (2023) Vol. 15, Iss. 5, pp. 1366-1366
Open Access | Times Cited: 4
Case report: Composite mantle cell lymphoma and classical Hodgkin lymphoma
Hongyu Wang, Liqun Yang, Qiuyao Li, et al.
Pathology & Oncology Research (2023) Vol. 29
Open Access | Times Cited: 4
Hongyu Wang, Liqun Yang, Qiuyao Li, et al.
Pathology & Oncology Research (2023) Vol. 29
Open Access | Times Cited: 4
A novel prognostic nomogram based on imaging and molecular parameters for newly diagnosed extranodal natural killer/T-cell lymphoma patients
Dezhi Huang, Li Fu, Shijia Lin, et al.
Haematologica (2024)
Open Access | Times Cited: 1
Dezhi Huang, Li Fu, Shijia Lin, et al.
Haematologica (2024)
Open Access | Times Cited: 1
High expression of TMEM244 is associated with poor overall survival of patients with T-cell lymphoma
Cunte Chen, Shaohua Chen, Gengxin Luo, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Cunte Chen, Shaohua Chen, Gengxin Luo, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Clinical Value of ctDNA in Hematological Malignancies (Lymphomas, Multiple Myeloma, Myelodysplastic Syndrome, and Leukemia): A Meta-Analysis
Xiangyu Tan, Yan Han, Lei Chen, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 9
Xiangyu Tan, Yan Han, Lei Chen, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 9
The Novel Prognostic Index Model of Combining Circulating Tumor DNA and PINK-E Predicts the Clinical Outcomes for Newly Diagnosed Extranodal NK/T-cell Lymphoma
Dezhi Huang, Qiong Li, Xinlei Li, et al.
HemaSphere (2022) Vol. 7, Iss. 1, pp. e822-e822
Open Access | Times Cited: 6
Dezhi Huang, Qiong Li, Xinlei Li, et al.
HemaSphere (2022) Vol. 7, Iss. 1, pp. e822-e822
Open Access | Times Cited: 6
How molecular advances may improve the diagnosis and management of PTCL patients
Fanny Drieux, François Lemonnier, Philippe Gaulard
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Fanny Drieux, François Lemonnier, Philippe Gaulard
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Liquid biopsy in lymphoma: Is it primed for clinical translation?
Edward Poynton, Jessica Okosun
eJHaem (2021) Vol. 2, Iss. 3, pp. 616-627
Open Access | Times Cited: 8
Edward Poynton, Jessica Okosun
eJHaem (2021) Vol. 2, Iss. 3, pp. 616-627
Open Access | Times Cited: 8
Mutation profiling of circulating tumor DNA identifies distinct mutation patterns in non‐Hodgkin lymphoma
Haiying Fu, Jianzhen Shen, Huarong Zhou, et al.
European Journal Of Haematology (2022) Vol. 108, Iss. 4, pp. 298-309
Closed Access | Times Cited: 4
Haiying Fu, Jianzhen Shen, Huarong Zhou, et al.
European Journal Of Haematology (2022) Vol. 108, Iss. 4, pp. 298-309
Closed Access | Times Cited: 4
Towards Next Generation Biomarkers in Natural Killer/T-Cell Lymphoma
Jason Yongsheng Chan, Jing Quan Lim, Choon Kiat Ong
Life (2021) Vol. 11, Iss. 8, pp. 838-838
Open Access | Times Cited: 5
Jason Yongsheng Chan, Jing Quan Lim, Choon Kiat Ong
Life (2021) Vol. 11, Iss. 8, pp. 838-838
Open Access | Times Cited: 5
Liquid Biopsy in Cancer: Focus on Lymphoproliferative Disorders
Francesco Savino, Fabio Rigali, Viviana Giustini, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5378-5378
Open Access | Times Cited: 3
Francesco Savino, Fabio Rigali, Viviana Giustini, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5378-5378
Open Access | Times Cited: 3
Genomics and Epigenomics of Natural Killer/T Cell Lymphoma: Diagnostic, Prognostic, and Therapeutic Implications
Yuan Tan, Can Küçük, Liyan Cui
Springer eBooks (2024)
Closed Access
Yuan Tan, Can Küçük, Liyan Cui
Springer eBooks (2024)
Closed Access